Viewing StudyNCT00376883



Ignite Creation Date: 2024-05-05 @ 5:02 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00376883
Status: COMPLETED
Last Update Posted: 2007-01-04
First Post: 2006-09-14

Brief Title: Pamidronate Prophylaxis in Multiple Myeloma 30 mgMonth Versus 90 mgMonth
Sponsor: Nordic Myeloma Study Group
Organization: Nordic Myeloma Study Group

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Keywords:
Name View
survival View
multiple myeloma View
pamidronate prophylaxis View
dose comparison View
quality of life View
skeletal event View
response View